Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The complement system is a critical component of the innate immune response, with three major activation pathways: classical, lectin, and alternative. The mannan-binding lectin–associated serine proteases (MASPs)—especially MASP-1, MASP-2, and MASP-3—are serine protease enzymes that mediate the lectin pathway, serving as key activators upon recognition of pathogen-associated ligands. Specifically, MASP-2 cleaves C4 and C2 to generate C3 convertase, driving formation of downstream effector complexes, while MASP-1 and MASP-3 regulate this pathway and can also activate the alternative pathway indirectly by activating complement factor D[1][3][4][5]. Dysregulation of MASPs or aberrant lectin pathway activity is implicated in a range of inflammatory and autoimmune diseases, and they are emerging as potential therapeutic targets for complement-driven pathology. For structured data systems, it is preferable to list the individual MASPs (MASP-1, MASP-2, MASP-3) as explicit targets rather than the vague “complement system via MASPs activation.”
Inhibition of MASP-2: Blocks cleavage of C4 and C2, preventing lectin pathway activation and downstream complement cascade. Inhibition of MASP-3: Prevents activation of complement factor D, reducing alternative pathway activity.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Complement system (via mannose-binding lectin-associated serine proteases activation) (null).